448 results on '"Ridnour, Lisa"'
Search Results
2. A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity
3. NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.
4. NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER-Breast Cancer
5. Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients
6. Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs
7. Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation
8. Nitric Oxide Regulates Angiogenesis through a Functional Switch Involving Thrombospondin-1
9. Thrombospondin-1 Inhibits Endothelial Cell Responses to Nitric Oxide in a cGMP-Dependent Manner
10. Hypoxic Inducible Factor 1 α, Extracellular Signal-Regulated Kinase, and p53 Are Regulated by Distinct Threshold Concentrations of Nitric Oxide
11. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
12. Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
13. Bromination of Deoxycytidine by Eosinophil Peroxidase: A Mechanism for Mutagenesis by Oxidative Damage of Nucleotide Precursors
14. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
15. IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium
16. Abstract 2539: Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces cytokine release via the alternative NFKB2 pathway in triple negative breast cancer cells (TNBC) and modulates neutrophil chemotaxis
17. Supplementary Figure 2 from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
18. Supplementary Figure 1 from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
19. Data from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
20. Supplementary Methods and Materials from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
21. Supplementary Figure Legends 1-2 from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
22. Biological signaling by small inorganic molecules
23. Supplementary Data from A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide
24. Supplementary Tables 1 - 2 from NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay
25. Supplementary Methods from Dithiolethiones Inhibit NF-κB Activity via Covalent Modification in Human Estrogen Receptor–Negative Breast Cancer
26. Supplemental Figure S3 from CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
27. Data from NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay
28. Data from Dithiolethiones Inhibit NF-κB Activity via Covalent Modification in Human Estrogen Receptor–Negative Breast Cancer
29. Supplemental Figure Legend from CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
30. Data from CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
31. Supplementary Table 1 from Dithiolethiones Inhibit NF-κB Activity via Covalent Modification in Human Estrogen Receptor–Negative Breast Cancer
32. Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells
33. New nitrosyl ruthenium complexes with combined activities for multiple cardiovascular disorders
34. The chemical biology of NO that regulates oncogenic signaling and metabolism: NOS2 and its role in inflammatory disease
35. Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
36. Nitric Oxide and Cancer: An Overview
37. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression
38. Contributors
39. NO in Cancer—Carcinogenesis, Metastasis, and Therapy
40. Erratum to: Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
41. Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome.
42. Abstract 3804: Interferon gamma induces NOS2 and COX2 expression in estrogen receptor negative breast cancer leading to immunosuppressive tumor microenvironment
43. NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+T Cell Spatial Orientation and Density
44. Thiolutin Inhibits Endothelial Cell Adhesion by Perturbing Hsp27 Interactions with Components of the Actin and Intermediate Filament Cytoskeleton
45. Nitric Oxide Regulates Matrix Metalloproteinase-9 Activity by Guanylyl-Cyclase-Dependent and -Independent Pathways
46. HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation
47. NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8 T Cell Spatial Orientation and Density
48. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells
49. Nitric Oxide and Cancer: When to Give and When to Take Away?
50. Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.